A Pilot Study: The Beneficial Effects of Combined Statinexercise Therapy on Cognitive Function in Patients with Coronary Artery Disease and Mild Cognitive Decline

被引:8
作者
Toyama, Kensuke [1 ]
Sugiyama, Seigo [1 ,5 ]
Oka, Hideki [6 ]
Hamada, Mari [6 ]
Iwasaki, Yuri [7 ]
Horio, Eiji [2 ]
Rokutanda, Taku [2 ]
Nakamura, Shinichi [2 ]
Spin, Joshua M. [3 ,4 ]
Tsao, Philip S. [3 ,4 ]
Ogawa, Hisao [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan
[2] Hitoyoshi Med Ctr, Japan Community Hlth Care Org, Div Cardiol, Hitoyoshi, Kumamoto, Japan
[3] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA
[4] VA Palo Alto Hlth Care Syst, Livermore, CA USA
[5] Jinnouchi Hosp, Diabet Care Ctr, Kumamoto, Kumamoto, Japan
[6] Nijigaoka Hosp, Div Cardiol & Cardiac Rehabil, Nagasaki, Nagasaki, Japan
[7] Hitoyoshi Med Ctr, Japan Community Hlth Care Org, Clin Res Ctr, Hitoyoshi, Kumamoto, Japan
关键词
statins; exercise; cognition; coronary artery disease; AEROBIC EXERCISE; OLDER-ADULTS; DEMENTIA; STATINS;
D O I
10.2169/internalmedicine.56.7703
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Hypercholesterolemia, a risk factor in cognitive impairment, can be treated with statins. However, cognitive decline associated with "statins" (HMG-CoA reductase inhibitors) is a clinical concern. This pilot study investigated the effects of combining statins and regular exercise on cognitive function in coronary artery disease (CAD) patients with prior mild cognitive decline. Methods We recruited 43 consecutive CAD patients with mild cognitive decline. These patients were treated with a statin and weekly in-hospital aerobic exercise for 5 months. We measured serum lipids, exercise capacity, and cognitive function using the mini mental state examination (MMSE). Results Low-density lipoprotein cholesterol levels were significantly decreased, and maximum exercise capacity (workload) was significantly increased in patients with CAD and mild cognitive decline after treatment compared with before. Combined statin-exercise therapy significantly increased the median (range) MMSE score from 24 (22-25) to 25 (23-27) across the cohort (p<0.01). Changes in body mass index (BMI) were significantly and negatively correlated with changes in the MMSE. After treatment, MMSE scores in the subgroup of patients that showed a decrease in BMI were significantly improved, but not in the BMI-increased subgroup. Furthermore, the patients already on a statin at the beginning of the trial displayed a more significant improvement in MMSE score than statin-naive patients, implying that exercise might be the beneficial aspect of this intervention as regards cognition. In a multivariate logistic regression analysis adjusted for age >65 years, sex, and presence of diabetes mellitus, a decrease in BMI during statin-exercise therapy was significantly correlated with an increase in the MMSE score (odds ratio: 4.57, 95% confidence interval: 1.0520.0; p<0.05). Conclusion Statin-exercise therapy may help improve cognitive dysfunction in patients with CAD and preexisting mild cognitive decline.
引用
收藏
页码:641 / 649
页数:9
相关论文
共 20 条
  • [1] [Anonymous], FDA DRUG SAF COMM IM
  • [2] Effects of Aerobic Exercise on Mild Cognitive Impairment A Controlled Trial
    Baker, Laura D.
    Frank, Laura L.
    Foster-Schubert, Karen
    Green, Pattie S.
    Wilkinson, Charles W.
    McTiernan, Anne
    Plymate, Stephen R.
    Fishel, Mark A.
    Watson, G. Stennis
    Cholerton, Brenna A.
    Duncan, Glen E.
    Mehta, Pankaj D.
    Craft, Suzanne
    [J]. ARCHIVES OF NEUROLOGY, 2010, 67 (01) : 71 - 79
  • [3] Aerobic exercise effects on cognitive and neural plasticity in older adults
    Erickson, K. I.
    Kramer, A. F.
    [J]. BRITISH JOURNAL OF SPORTS MEDICINE, 2009, 43 (01) : 22 - 24
  • [4] Hurd MD, 2013, NEW ENGL J MED, V369, P489, DOI [10.1056/NEJMsa1204629, 10.1056/NEJMc1305541]
  • [5] Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease
    Kivipelto, M
    Ngandu, T
    Fratiglioni, L
    Viitanen, M
    Kåreholt, I
    Winblad, B
    Helkala, EL
    Tuomilehto, J
    Soininen, H
    Nissinen, A
    [J]. ARCHIVES OF NEUROLOGY, 2005, 62 (10) : 1556 - 1560
  • [6] Functional Characterization of Mouse Organic Anion Transporting Peptide 1a4 in the Uptake and Efflux of Drugs Across the Blood-Brain Barrier
    Ose, Atsushi
    Kusuhara, Hiroyuki
    Endo, Chihiro
    Tohyama, Kimio
    Miyajima, Mari
    Kitamura, Satoshi
    Sugiyama, Yuichi
    [J]. DRUG METABOLISM AND DISPOSITION, 2010, 38 (01) : 168 - 176
  • [7] The Effect of HMG-CoA Reductase Inhibitors on Cognition in Patients With Alzheimer's Dementia: A Prospective Withdrawal and Rechallenge Pilot Study
    Padala, Kalpana P.
    Padala, Prasad R.
    McNeilly, Dennis P.
    Geske, Jenenne A.
    Sullivan, Dennis H.
    Potter, Jane F.
    [J]. AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2012, 10 (05) : 296 - 302
  • [8] Statins and Cognitive Function
    Richardson, Karl
    Schoen, Marisa
    French, Benjamin
    Umscheid, Craig A.
    Mitchell, Matthew D.
    Arnold, Steven E.
    Heidenreich, Paul A.
    Rader, Daniel J.
    deGoma, Emil M.
    [J]. ANNALS OF INTERNAL MEDICINE, 2013, 159 (10) : 688 - +
  • [9] An assessment by the Statin Cognitive Safety Task Force: 2014 update
    Rojas-Fernandez, Carlos H.
    Goldstein, Larry B.
    Levey, Allan I.
    Taylor, Beth A.
    Bittner, Vera
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (03) : S5 - S16
  • [10] Is Statin-Associated Cognitive Impairment Clinically Relevant? A Narrative Review and Clinical Recommendations
    Rojas-Fernandez, Carlos H.
    Cameron, Jean-Christy F.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (04) : 549 - 557